Participants should be given feedback about the trialBMJ 1996; 312 doi: https://doi.org/10.1136/bmj.312.7024.186a (Published 20 January 1996) Cite this as: BMJ 1996;312:186
- Sally Marshall
- Clinical metrologist Rheumatology Department, Mount Gould Hospital, Plymouth PL4 7QD
EDITOR,—Elizabeth Wager and colleagues have set out extremely useful guidelines for gaining patients' consent to enter clinical trials.1 I have undertaken an anonymous, retrospective postal survey of 90 patients who participated in five trials of treatment for rheumatoid arthritis and one for ankylosing spondylitis. Seventy patients returned questionnaires (78% response rate). Most (69) thought that they had received a full explanation of the study and (67) that they had not been put under any pressure to take part, and all …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial